Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.035 USD | -30.00% | -30.00% | -95.00% |
Apr. 11 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Financials (USD)
Sales 2021 | 2.21M | Sales 2022 | 4.76M | Capitalization | 25.39M |
---|---|---|---|---|---|
Net income 2021 | -45M | Net income 2022 | -26M | EV / Sales 2021 | 31.5 x |
Net cash position 2021 | 20.53M | Net cash position 2022 | 433K | EV / Sales 2022 | 5.25 x |
P/E ratio 2021 |
-1.9
x | P/E ratio 2022 |
-0.96
x | Employees | 12 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 90.68% |
Latest transcript on DMK Pharmaceuticals Corporation
1 day | -0.60% | ||
Current month | -3.85% | ||
1 month | -18.70% | ||
3 months | -91.15% | ||
6 months | -91.39% | ||
Current year | -92.86% |
Managers | Title | Age | Since |
---|---|---|---|
Ebrahim Versi
CEO | Chief Executive Officer | 71 | 23-05-24 |
Seth Cohen
DFI | Director of Finance/CFO | 42 | 23-10-15 |
Robert H. Uhl
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Howard Birndorf
BRD | Director/Board Member | 74 | 19-08-25 |
Ebrahim Versi
CEO | Chief Executive Officer | 71 | 23-05-24 |
Vickie Reed
BRD | Director/Board Member | 62 | 22-05-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 0.035 | -30.00% | 67 342 |
24-04-22 | 0.05 | -0.60% | 11,725 |
24-04-19 | 0.0503 | +0.60% | 48,228 |
24-04-18 | 0.05 | -0.20% | 71,802 |
24-04-17 | 0.0501 | +0.20% | 3,167 |
Delayed Quote OTC Markets, April 22, 2024 at 11:33 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-92.86% | 505K | |
+25.46% | 659B | |
+26.79% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.53% | 215B | |
+7.61% | 210B | |
-6.05% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- DMKPQ Stock